Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Nigella sativa in controlling Type 2 diabetes, cardiovascular, and rheumatoid arthritis diseases: molecular aspects
Market Segmentation Global Glucagon-Like Peptide-1 Agonists Market Size, Share & Industry Analysis, By Product Type (Short-Acting GLP-1 Agonists, Long-Acting GLP-1 Agonists), By Route of Administration (Injectable, Oral), By Application (Type 2 Diabetes, Obesity Management, Cardiovascular Disease Management), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 20262035 Global Glucagon-Like Peptide-1 Agonists Market Size & Statistics The Market size of global glucagon-like peptide-1 agonists was estimated to be worth USD 46.18 Billion in 2025
They hypothesised that an animals natural pigmentary system could be stimulated to produce a safe and protective tan before UV exposure
Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway
In three studies, supplementations were combined with carbohydrates (CHO) [5,6,7], and in one with L-leucine [18]
US$ 20.84
US$ 25.26
US$ 28.65
US$ 20.21
US$ 28.60
US$ 29.66
US$ 20.18
US$ 27.80
US$ 21.66
US$ 25.53
